Page 3 - Michaela Dinerman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viking Therapeutics (NASDAQ:VKTX – Get Rating) and NeuroBo Pharmaceuticals (NASDAQ:NRBO – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Insider and Institutional Ownership 34.7% of Viking Therapeutics shares are […]

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) – Analysts at William Blair boosted their Q2 2023 EPS estimates for Viking Therapeutics in a note issued to investors on Wednesday, April 26th. William Blair analyst A. Hsieh now anticipates that the biotechnology company will earn ($0.21) per share for the quarter, up from their prior estimate […]

Viking Therapeutics (NASDAQ:VKTX – Get Rating) and NeuroBo Pharmaceuticals (NASDAQ:NRBO – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation. Volatility & Risk Viking Therapeutics has a beta of […]

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price objective upped by HC Wainwright from $21.00 to $33.00 in a report published on Thursday morning, The Fly reports. A number of other brokerages have also recently issued reports on VKTX. Raymond James upped their price objective on shares of Viking Therapeutics from $12.00 to $35.00 […]

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) shares hit a new 52-week high during trading on Monday . The company traded as high as $22.33 and last traded at $21.88, with a volume of 1212585 shares. The stock had previously closed at $21.31. Wall Street Analysts Forecast Growth VKTX has been the topic of a […]